Secondary progressive multiple sclerosis: treatments, associated drugs and conditions

Summary:

Secondary progressive multiple sclerosis: a stage of ms which comes after relapsing remitting ms in many cases.

We study 11,840 people who have Secondary progressive multiple sclerosis. The information that eHealthMe analyzes includes:

- Medications that treat Secondary progressive multiple sclerosis and their effectiveness
- 139 drugs that are associated with Secondary progressive multiple sclerosis



Number of reports submitted per year:

Secondary progressive multiple sclerosis: 11,840 reports.

Secondary progressive multiple sclerosis treatments and how effective are they?

All the drugs that are associated with Secondary progressive multiple sclerosis:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: